Recent research analyzed factors influencing the selection of the first-line biologic medications and the real-life factors that lead to switching from those medications to other biologics in treating rheumatoid arthritis (RA). The study compared the use of abatacept and tocilizumab with a tumor necrosis factor alpha inhibitor (TNFi).1,2 Participants were enrolled in the Lombardy Rheumatology…
Outdoor Lifestyle Is Lifelong Pursuit for Rheumatologist Dr. Mary Moran
Mary Moran (now an MD) had just turned 20 years old and wondered if she’d make it through that day in May. She was sailing on a 30-foot open boat—no cabin below—for 26 days off the coast of Maine with 10 strangers who knew very little about sailing. On the third day, storm clouds rolled…
Credit Card Program Helps Physician Practice Manage Its Income
As Erin L. Arnold, MD, partner, Orthopaedics and Rheumatology of the North Shore, in Skokie, Ill, observed patients’ health insurance deductibles and copays getting dramatically higher and higher, she decided that it was time to explore a program that would require patients to keep a credit card on file. “As a private practice and small…
fMRI Can Help Diagnose Fibromyalgia
Brain imaging can distinguish fibromyalgia patients from healthy controls with high sensitivity and specificity, according to two papers published nearly simultaneously in Pain late last summer, by groups at the Universities of Colorado and Michigan, respectively. Somewhat surprisingly to the authors and others, in the Colorado study, which used both painful and nonpainful stimuli, the…
Environmental Factors in Pediatric Systemic Autoimmune Diseases
Systemic autoimmune diseases are thought to result from immune dysregulation in genetically susceptible individuals who were exposed to environmental risk factors. Many studies have identified genetic risk factors for these diseases, but concordance rates among monozygotic twins are 25–40%, suggesting that nonheritable environmental factors play a more prominent role.1,2 Through carefully conducted epidemiologic and other…
Metagenomic Deep Sequencing for Uveitis Enhances Traditional Diagnostic Testing
Throughout their training and practice, physicians become adept at pattern recognition as a means to efficiently connect and synthesize seemingly disparate laboratory, physical exam, and radiologic and historical findings into a coherent theory for what likely ails the patient sitting in front of them. This inductive method of reasoning is necessary because, based on these…
Undercoding Is Not an Audit-Proof Strategy in Medical Documentation
Overcoding is a common term used when discussing fraud and abuse in reporting procedures and services not supported by the actual work performed. Alternatively, undercoding—or failing to report the full extent of services or procedures provided—is an equally unsound practice and a compliance risk. In the world of quality reporting, undercoding can have damaging effects…
How to Diagnose Antisynthetase Syndrome
Antisynthetase syndrome (AS) is strongly associated with the presence of antibodies to aminoacyl-transfer RNA (tRNA) synthetases (ARSs) that are implicated in the pathogenesis of myositis and interstitial lung disease (ILD). Antibodies against eight antisynthetases have been identified and are detected in 16–26% of patients with idiopathic inflammatory myopathies (IIM).1 Serum assays for five of these…
ACR Puts Forward Principles on Patient Access to Care
The ACR has partnered with the American Medical Association (AMA) and over a dozen stakeholder groups to create a set of 21 principles to reform prior authorization protocols. This coalition represents hospitals, medical groups, patients, pharmacists and physicians with a unified goal of creating a more patient-centered, streamlined and transparent process for prior authorization. According…
Rheumatology Research Foundation Reaches $60 Million Journey to Cure Goal
The Rheumatology Research Foundation is pleased to announce the overwhelming success of the Journey to Cure campaign. With a goal of raising $60 million, this five-year campaign was created to directly invest in the future of rheumatology by supporting training opportunities and funding innovative research. The campaign surpassed its goal, with a grand total of…
- « Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- …
- 103
- Next Page »